Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1955 2
1958 1
1959 1
1963 1
1965 3
1966 5
1967 10
1968 9
1969 16
1970 16
1971 27
1972 29
1973 31
1974 51
1975 145
1976 146
1977 145
1978 125
1979 161
1980 147
1981 154
1982 171
1983 201
1984 238
1985 276
1986 247
1987 243
1988 243
1989 358
1990 387
1991 485
1992 602
1993 811
1994 957
1995 914
1996 1006
1997 1177
1998 1425
1999 1872
2000 2164
2001 2628
2002 2962
2003 3984
2004 4253
2005 4582
2006 4296
2007 4979
2008 5427
2009 5759
2010 6063
2011 6235
2012 6645
2013 7091
2014 7255
2015 7147
2016 7009
2017 7322
2018 7405
2019 7299
2020 7004
2021 5289
2022 3297
2023 2623
2024 796

Text availability

Article attribute

Article type

Publication date

Search Results

125,707 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Illness (finding)"
Page 1
Long COVID, a comprehensive systematic scoping review.
Akbarialiabad H, Taghrir MH, Abdollahi A, Ghahramani N, Kumar M, Paydar S, Razani B, Mwangi J, Asadi-Pooya AA, Malekmakan L, Bastani B. Akbarialiabad H, et al. Infection. 2021 Dec;49(6):1163-1186. doi: 10.1007/s15010-021-01666-x. Epub 2021 Jul 28. Infection. 2021. PMID: 34319569 Free PMC article. Review.
Of the total 120 publications, 49.1% focused on signs and symptoms, 23.3% on management, and 10.8% on pathophysiology. ...The results are also presented extensively in a narrative synthesis in separated sections (nomenclature, diagnosis, pathophysiolog …
Of the total 120 publications, 49.1% focused on signs and symptoms, 23.3% on management, and 10.8% on pathophysiology. …
Antidepressants and body weight: a comprehensive review and meta-analysis.
Serretti A, Mandelli L. Serretti A, et al. J Clin Psychiatry. 2010 Oct;71(10):1259-72. doi: 10.4088/JCP.09r05346blu. J Clin Psychiatry. 2010. PMID: 21062615 Review.
OBJECTIVE: Psychotropic drugs often induce weight gain, leading to discomfort and discontinuation of treatment and, more importantly, increasing the risk of obesity-related illnesses such as diabetes mellitus, hypertension, and coronary heart disease. ...Data presented may …
OBJECTIVE: Psychotropic drugs often induce weight gain, leading to discomfort and discontinuation of treatment and, more importantly, increa …
Lactobacillus reuteri to Treat Infant Colic: A Meta-analysis.
Sung V, D'Amico F, Cabana MD, Chau K, Koren G, Savino F, Szajewska H, Deshpande G, Dupont C, Indrio F, Mentula S, Partty A, Tancredi D. Sung V, et al. Pediatrics. 2018 Jan;141(1):e20171811. doi: 10.1542/peds.2017-1811. Pediatrics. 2018. PMID: 29279326 Review.
DATA SOURCES: We searched online databases (PubMed, Medline, Embase, the Cumulative Index to Nursing and Allied Health Literature, the Database of Abstracts of Reviews of Effects, and Cochrane), e-abstracts, and clinical trial registries. STUDY SELECTION: These were …
DATA SOURCES: We searched online databases (PubMed, Medline, Embase, the Cumulative Index to Nursing and Allied Health Literature, the Datab …
Septic Shock: Advances in Diagnosis and Treatment.
Seymour CW, Rosengart MR. Seymour CW, et al. JAMA. 2015 Aug 18;314(7):708-17. doi: 10.1001/jama.2015.7885. JAMA. 2015. PMID: 26284722 Free PMC article. Review.
IMPORTANCE: Septic shock is a clinical emergency that occurs in more than 230,000 US patients each year. ...Hydroxyethyl starch is no longer recommended, and debate continues about the role of various crystalloid solutions and albumin. CONCLUSIONS AND RELEVANCE: The prompt …
IMPORTANCE: Septic shock is a clinical emergency that occurs in more than 230,000 US patients each year. ...Hydroxyethyl starch is no …
Neurologic and neuropsychiatric syndrome features of mold and mycotoxin exposure.
Empting LD. Empting LD. Toxicol Ind Health. 2009 Oct-Nov;25(9-10):577-81. doi: 10.1177/0748233709348393. Toxicol Ind Health. 2009. PMID: 19854819
Human exposure to molds, mycotoxins, and water-damaged buildings can cause neurologic and neuropsychiatric signs and symptoms. Many of these clinical features can partly mimic or be similar to classic neurologic disorders including pain syndromes, move …
Human exposure to molds, mycotoxins, and water-damaged buildings can cause neurologic and neuropsychiatric signs and sympto …
Antipyretic drugs in patients with fever and infection: literature review.
Ludwig J, McWhinnie H. Ludwig J, et al. Br J Nurs. 2019 May 23;28(10):610-618. doi: 10.12968/bjon.2019.28.10.610. Br J Nurs. 2019. PMID: 31116598 Review.
CONCLUSION: the evidence does not currently support routine antipyretic administration. Considering patients' comorbidities and symptoms of their underlying illness will promote safe, evidence-based and appropriate administration of antipyretics....
CONCLUSION: the evidence does not currently support routine antipyretic administration. Considering patients' comorbidities and symptoms …
Facial exercise therapy for facial palsy: systematic review and meta-analysis.
Pereira LM, Obara K, Dias JM, Menacho MO, Lavado EL, Cardoso JR. Pereira LM, et al. Clin Rehabil. 2011 Jul;25(7):649-58. doi: 10.1177/0269215510395634. Epub 2011 Mar 7. Clin Rehabil. 2011. PMID: 21382865 Review.
DATA SOURCES: A search was performed in the following databases: Cochrane Controlled Trials Register Library, Cochrane Disease Group Trials Register, MEDLINE, EMBASE, LILACS, PEDro, Scielo and DARE from 1966 to 2010; the following keywords were used: 'idiopathic facial palsy', 'f …
DATA SOURCES: A search was performed in the following databases: Cochrane Controlled Trials Register Library, Cochrane Disease Group Trials …
Abrocitinib efficacy and safety in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study.
Reich K, Silverberg JI, Papp KA, Deleuran M, Katoh N, Strober B, Beck LA, de Bruin-Weller M, Werfel T, Zhang F, Biswas P, DiBonaventura MD, Chan G, Johnson S, Farooqui SA, Kerkmann U, Clibborn C. Reich K, et al. J Eur Acad Dermatol Venereol. 2023 Oct;37(10):2056-2066. doi: 10.1111/jdv.19280. Epub 2023 Jul 11. J Eur Acad Dermatol Venereol. 2023. PMID: 37335885
BACKGROUND: Abrocitinib improved signs and symptoms of moderate-to-severe atopic dermatitis (AD) at 12 or 16 weeks in phase 3 studies with a manageable safety profile. ...
BACKGROUND: Abrocitinib improved signs and symptoms of moderate-to-severe atopic dermatitis (AD) at 12 or 16 weeks in p …
Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial.
Simpson EL, Silverberg JI, Thyssen JP, Viguier M, Thaçi D, de Bruin-Weller M, Weidinger S, Chan G, DiBonaventura M, Biswas P, Feeney C, Koulias C, Cork MJ. Simpson EL, et al. Am J Clin Dermatol. 2023 Jul;24(4):609-621. doi: 10.1007/s40257-023-00785-5. Epub 2023 May 22. Am J Clin Dermatol. 2023. PMID: 37213005 Free PMC article. Clinical Trial.
BACKGROUND: Traditional systemic immunosuppressants and advanced therapies improve signs and symptoms of moderate-to-severe atopic dermatitis (AD). ...Many of these people had severe symptoms when they entered the study. Some had AD signs and …
BACKGROUND: Traditional systemic immunosuppressants and advanced therapies improve signs and symptoms of moderate-to-se …
The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation.
Van Dongen HP, Maislin G, Mullington JM, Dinges DF. Van Dongen HP, et al. Sleep. 2003 Mar 15;26(2):117-26. doi: 10.1093/sleep/26.2.117. Sleep. 2003. PMID: 12683469 Clinical Trial.
DESIGN: The chronic sleep restriction experiment involved randomization to one of three sleep doses (4 h, 6 h, or 8 h time in bed per night), which were maintained for 14 consecutive days. ...
DESIGN: The chronic sleep restriction experiment involved randomization to one of three sleep doses (4 h, 6 h, or 8 h time in bed per …
125,707 results
You have reached the last available page of results. Please see the User Guide for more information.